Literature DB >> 4371063

A trial of corticotrophin gelatin injection in acute optic neuritis.

A N Bowden, P M Bowden, A I Friedmann, G D Perkin, F C Rose.   

Abstract

The effect of a 30 day course of corticotrophin gelatin injections on the natural history of acute unilateral optic neuritis in 27 patients is reported. A further 27 patients received inert injections in a double-blind control. Measurements were made on visual acuity, visual field, macular threshold, and colour vision, and the development of optic atrophy and other neurological episodes was recorded. No significant differences were found between treated and control groups at intervals up to two years from the start of the trial. The criteria for inclusion of patients are given and it is concluded that corticotrophin has no effect on the natural history of the condition as defined.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4371063      PMCID: PMC494799          DOI: 10.1136/jnnp.37.8.869

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  11 in total

1.  The present status of ACTH therapy in multiple sclerosis.

Authors:  L ALEXANDER; L J CASS
Journal:  Ann Intern Med       Date:  1963-03       Impact factor: 25.391

2.  Follow-up on patients with a history of optic neuritis.

Authors:  K HYLLESTED; P M MOLLER
Journal:  Acta Ophthalmol (Copenh)       Date:  1961

3.  Retrobulbar neuritis. A survey of the present condition of cases occurring over the last fifty-six years.

Authors:  B H LYNN
Journal:  Trans Ophthalmol Soc U K       Date:  1959

4.  Multiple sclerosis. Treatment of acute exacerbations with corticotrophin (A.C.T.H.).

Authors:  H MILLER; D J NEWELL; A RIDLEY
Journal:  Lancet       Date:  1961-11-18       Impact factor: 79.321

5.  Treatment of acute retrobulbar neuritis with corticotrophin.

Authors:  M D Rawson; L A Liversedge; G Goldfarb
Journal:  Lancet       Date:  1966-11-12       Impact factor: 79.321

6.  Long-term treatment of multiple sclerosis with corticotrophin.

Authors:  J H Millar; C J Vas; M J Noronha; L A Liversedge; M D Rawson
Journal:  Lancet       Date:  1967-08-26       Impact factor: 79.321

7.  Corticotrophin treatment in multiple sclerosis.

Authors:  U K Rinne; V Sonninen; T Tuovinen
Journal:  Acta Neurol Scand       Date:  1968       Impact factor: 3.209

8.  Treatment of retrobulbar neuritis with corticotrophin.

Authors:  M D Rawson; L A Liversedge
Journal:  Lancet       Date:  1969-07-26       Impact factor: 79.321

9.  Acute optic neuritis: its clinical features and their relation to prognosis for recovery of vision.

Authors:  W G Bradley; C W Whitty
Journal:  J Neurol Neurosurg Psychiatry       Date:  1967-12       Impact factor: 10.154

10.  Serial analysis of changes in visual field defects, employing a new instrument, to determine the activity of diseases involving the visual pathways.

Authors:  A I Friedmann
Journal:  Ophthalmologica       Date:  1966       Impact factor: 3.250

View more
  9 in total

Review 1.  The ocular manifestations of multiple sclerosis. 1. Abnormalities of the afferent visual system.

Authors:  W I McDonald; D Barnes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-09       Impact factor: 10.154

Review 2.  Corticosteroids for treating optic neuritis.

Authors:  Robin L Gal; Satyanarayana S Vedula; Roy Beck
Journal:  Cochrane Database Syst Rev       Date:  2015-08-14

3.  Uhthoff's syndrome.

Authors:  G D Perkin; F C Rose
Journal:  Br J Ophthalmol       Date:  1976-01       Impact factor: 4.638

Review 4.  Corticosteroids for treating optic neuritis.

Authors:  S S Vedula; S Brodney-Folse; R L Gal; R Beck
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

Review 5.  Corticosteroids for treating optic neuritis.

Authors:  Robin L Gal; Satyanarayana S Vedula; Roy Beck
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18

6.  Treatmenf of optic neuritis by retrobulbar injection of triamcinolone.

Authors:  E S Gould; A C Bird; P K Leaver; W I McDonald
Journal:  Br Med J       Date:  1977-06-11

7.  Optic neuropathy in sarcoidosis.

Authors:  E M Graham; C J Ellis; M D Sanders; W I McDonald
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-07       Impact factor: 10.154

Review 8.  Re-evaluating the treatment of acute optic neuritis.

Authors:  Jeffrey L Bennett; Molly Nickerson; Fiona Costello; Robert C Sergott; Jonathan C Calkwood; Steven L Galetta; Laura J Balcer; Clyde E Markowitz; Timothy Vartanian; Mark Morrow; Mark L Moster; Andrew W Taylor; Thaddeus W W Pace; Teresa Frohman; Elliot M Frohman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-10-29       Impact factor: 10.154

9.  Oral lipoic acid as a treatment for acute optic neuritis: a blinded, placebo controlled randomized trial.

Authors:  Julie Falardeau; Allison Fryman; Rohan Wanchu; Gail H Marracci; Michele Mass; Lindsey Wooliscroft; Dennis N Bourdette; Charles F Murchison; William L Hills; Vijayshree Yadav
Journal:  Mult Scler J Exp Transl Clin       Date:  2019-05-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.